Skip to main content

and
  1. Article

    Open Access

    Ibuprofen, other NSAIDs and COVID-19: a narrative review

    At the start of the coronavirus disease 2019 (COVID-19) pandemic (March 2020), there was speculation that non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, used to manage some of the symptoms o...

    William Laughey, Imran Lodhi, Graham Pennick, Lucinda Smart in Inflammopharmacology (2023)

  2. Article

    Open Access

    A narrative review of the potential pharmacological influence and safety of ibuprofen on coronavirus disease 19 (COVID-19), ACE2, and the immune system: a dichotomy of expectation and reality

    The coronavirus disease 19 (COVID-19) pandemic is currently the most acute healthcare challenge in the world. Despite growing knowledge of the nature of Severe Acute Respiratory Syndrome coronavirus-2 (SARS-Co...

    Lucinda Smart, Neil Fawkes, Paul Goggin, Graham Pennick in Inflammopharmacology (2020)